Streetbeat News

Products Services

GMDA

Gamida Cell is actively exploring strategic alternatives while prioritizing the commercialization of its FDA-approved cell therapy, Omisirge (omidubicel-onlv).

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 11:01 am

AAPL

INTC

MSFT

NFLX

SPY

TSLA

TXN

The past week's earnings reports from companies like Tesla, Intel, and Texas Instruments were disappointing, affecting market sentiment. However, Netflix's strong performance provided some optimism. With 25% of S&P 500 companies having reported, 69% beat EPS estimates and 68% beat revenue estimates. The upcoming week is tech-heavy with earnings from Microsoft and Apple being highly anticipated, especially Microsoft's AI initiatives. FactSet expects six 'Mag 7' companies, excluding Tesla, to report a 53.7% year-over-year earnings growth for Q4. Energy sector earnings are also to be watched due to low crude oil prices. The SPDR S&P 500 ETF Trust (SPY) saw a slight premarket increase.

Portfolio Pulse from Shanthi Rexaline

January 29, 2024 | 10:51 am

RYAAY

During a conference call, Ryanair's CEO expressed full support for Boeing's CEO Calhoun and CFO West, and eagerly anticipates the delivery of the Boeing Max 10 aircraft.

Portfolio Pulse from Charles Gross

January 29, 2024 | 10:19 am

AAPL

Bloomberg columnist Mark Gurman suggests that iOS 18 could be the most significant update in iPhone history, with anticipated features like RCS support and enhanced Siri functionality using generative AI. Apple Inc. (NASDAQ:AAPL) plans to release iOS 18 in September, following a strategic pause in development to focus on AI capabilities and software quality. This update is crucial as Apple shifts focus to software innovation amid fewer hardware breakthroughs expected for the iPhone 16.

Portfolio Pulse from Ananya Gairola

January 29, 2024 | 9:52 am

ALVO

Alvotech (NASDAQ:ALVO) announced positive top-line results from a pharmacokinetic study for AVT03, a proposed biosimilar for Prolia and Xgeva. The study met its primary endpoints, demonstrating pharmacokinetics, safety, and tolerability of AVT03 compared to Prolia in healthy adults. Further studies, including a confirmatory efficacy study and a PK study comparing AVT03 to Xgeva, are in progress.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 9:02 am

BABA

BIDU

XIACF

China has approved over 40 AI models for public use in the last six months, aiming to compete with U.S. AI development. The approval process, introduced in August, has seen companies like Xiaomi, 4Paradigm, and 01.AI benefit from the endorsement of 14 large language models. Baidu, Alibaba, and ByteDance were among the first to receive approval. Despite the AI push, there hasn't been a significant increase in cloud services spending in China. Concerns over AI misuse for espionage have been raised by the FBI. Baidu's Ernie Bot reached 100 million users in December.

Portfolio Pulse from Benzinga Neuro

January 29, 2024 | 8:41 am

EADSY

UAL

United Airlines is in early discussions with Airbus to acquire more A321neo jets as a response to delays in the delivery of Boeing's 737 Max 10. United CEO Scott Kirby initiated the talks due to concerns over the Max 10's certification, exacerbated by a recent mid-air emergency with an Alaska Airlines 737 Max 9. United has not canceled its order for 277 Max 10 jets but has removed them from internal plans. Boeing faces challenges with the 737 Max 9, which was temporarily grounded due to a door plug incident, and ongoing quality issues that could impact the U.S. economy.

Portfolio Pulse from Benzinga Neuro

January 29, 2024 | 8:19 am

Toyota Motor Corp (NYSE:TM) is suspending shipments of 10 vehicle models due to certification irregularities with diesel engines supplied by Toyota Industries Corporation (TICO). The issue was identified during horsepower output testing for three diesel engine models, affecting global models such as Land Cruiser 300, Hilux, and Fortuner.

Portfolio Pulse from Anan Ashraf

January 29, 2024 | 7:40 am

AAPL

An iPhone user recovered their stolen iPhone 15 from an EcoATM kiosk at Walmart using Apple's 'Find My' app. The app's location tracking feature showed the phone's changing locations, leading to its recovery. This highlights the effectiveness of the 'Find My' feature, which has been updated in iOS 17 to help locate misplaced Apple Watches as well.

Portfolio Pulse from Rounak Jain

January 29, 2024 | 7:39 am

TAK

The European Commission has approved Takeda's HYQVIA as a maintenance therapy for patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). HYQVIA is the only facilitated subcutaneous immunoglobulin therapy that offers a once-monthly treatment option, which can be administered at home or in-office. This approval enhances Takeda's portfolio of immunoglobulin therapies for neuroimmunological disorders.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 7:21 am